With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social
And the benefits of GCGR agonists which reduce liver fat in people with obesity and MASLD.
@rarediseaseuk (on X) @CamMetaboNet (on X) @ims-mrl.bsky.social
And the benefits of GCGR agonists which reduce liver fat in people with obesity and MASLD.
@rarediseaseuk (on X) @CamMetaboNet (on X) @ims-mrl.bsky.social